Lindus Health Expands All-in-One CRO Capabilities with Enhanced In-House Patient Recruitment Capabilities

BOSTON, Oct. 9, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers has announced enhancements to its recruitment capabilities, which form a core part of its end-to-end trial delivery solution. All of Lindus' studies involve an innovative, technology-driven and patient-centric recruitment approach to accelerate trials, making it the only provider of a fully integrated clinical recruitment ecosystem.

Across the industry, patient recruitment and retention remains as one of the most challenging components of clinical trial delivery, directly impacting speed, costs and quality. An average of 82% of clinical trials within the industry experience delayed enrollment, which highlights the demand for novel, effective recruitment methods. Lindus Health's globally recognized unmatched performance has broken this pattern, earning the company the Fierce CRO Award in the Outstanding Patient Recruitment and Retention.

Lindus Health has been able to achieve on average 72.9% faster enrollment across all their studies to date through a vertically integrated approach that breaks the status quo. Unlike traditional CROs, Lindus Health offers a fully integrated in-house recruitment strategy as a part of their end-to-end offerings. The company aligns incentives to enrollments, enables real-time site capacity management, provides live funnel metrics across the entire patient journey, and houses a central Patient Recruitment Coordinator (PRC) team that manages all virtual patient interactions while collaborating with on-site coordinators where appropriate - all powered by one cohesive internal technology stack.

"Our multi-faceted recruitment model increases awareness, trust, and interest," said Meri Beckwith, Co-CEO of Lindus Health. "The result is a truly integrated flow that expands access and improves conversion."

Lindus Health's comprehensive recruitment process, as part of its end-to-end CRO offering, can be boiled down to three easy steps taking the patient from identification to enrollment harmoniously.

1. Omni-channel recruitment tailored to each study's unique needs: To identify ideal and diverse patients, Lindus Health leverages over 40 million electronic medical records (EMRs) in primary care (recognized in Lindus' recent win of the Fierce Biotech Patient recruitment award). This approach harnesses Artificial Intelligence (AI) to seamlessly integrate with and screen EMRs using advanced algorithms to cast a wide net that finds patients who optimally match the sponsor's inclusion/exclusion criteria. Other recruitment pathways such as geo-targeted digital advertising, and relationships with primary care networks, patient advocacy groups and community outreach channels help facilitate a holistic recruitment framework. Whether targeting self-identified patient populations or encountering complex inclusion criteria, Lindus Health brings deep expertise that matches a mix of patient identification tools unique to every trial it runs based on population and study model, with AI smoothly embedded throughout the entire process.
2. Central screening through in-house PRC team and AI integration: The gap between recruitment and sites is eliminated by PRCs that own patient relationships through personalized assistance and support across the entire patient journey. This includes all aspects of the virtual screening process, as well as direct coordination with research staff at physical sites when needed, ensuring seamless trial management. Alongside human specialists, Lindus Health also uses AI agents for pre–screening with full-spectrum capabilities such as answering patient questions, scheduling visits and triaging participants as a feature of its virtual site.
3. Flexible enrollment pathways and site models managed with Lindus Health's proprietary eClinical platform, Citrus™: Every participant flows through Lindus' centralized screening, while sponsors and patients can choose where enrollment occurs. This can be with the Lindus Virtual Site for studies that allow for fully remote assessments, utilize the Lindus Site Network for integrated local engagement, or expand to include External Sites for maximum sponsor flexibility - all fully supported by Lindus Health.

The intersection of data, technology and operations is the backbone of Lindus' strengthened recruitment practice that distinctly accommodates both sponsors and patients. "Our mission is to fix the broken trial model" said Michael Young, Co-CEO of Lindus Health "Faster, more inclusive recruitment is an integral part of our all-in-one CRO solution - the foundation of that change."

About Lindus Health

‍Lindus Health is the anti-CRO running radically faster, more reliable clinical trials for life science pioneers - bringing ground-breaking treatments to patients more quickly. By aligning incentives through a performance-based pricing model, combining a world-class clinical operations team with a proprietary software platform, and leveraging access to over 40 million Electronic Health Records, Lindus Health delivers trials designed for speed, reliability, and impact.

The biggest bottleneck in healthcare - clinical trials - is removed by Lindus Health via end-to-end study execution powered by technology and forward-thinking approaches to clinical operations. Lindus Health works with leading biotech, medical device, diagnostics, and consumer health companies to accelerate the development of innovative therapies and cutting-edge products.

To date, Lindus Health has delivered trials across the US, UK, and Europe in conditions ranging from diabetes and asthma to major depressive disorder, hypertension, and chronic fatigue syndrome. The company has raised over $80M from investors including Balderton, Peter Thiel, Creandum, Firstminute Capital, and Seedcamp.

Press Contact:
Jodi Perkins
Amendola Communications on Behalf of Lindus Health
[email protected]

SOURCE Lindus Health